|
Tue, 07/02/2024 - 10:34 |
U.S. Department of Justice Informs Viatris That It No Longer Considers Mylan a Subject of Generic Drug Industry Antitrust Investigation |
Viatris |
|
Wed, 01/30/2019 - 10:06 |
FDA approves first generic Advair Diskus |
FDA |
|
Tue, 12/11/2018 - 10:24 |
FDA warns API manufacturer involved in valsartan recall, provides information for patients taking these medications |
FDA |
|
Tue, 12/11/2018 - 07:07 |
Momenta Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters Option to Purchase Additional Shares |
Momenta |
|
Thu, 12/06/2018 - 06:37 |
UPDATE: Momenta Pharmaceuticals Announces Pricing of Public Offering of Common Stock |
Momenta |
|
Wed, 12/05/2018 - 07:20 |
Momenta Pharmaceuticals Announces Proposed Public Offering of Common Stock |
Momenta |
|
Mon, 12/03/2018 - 05:41 |
Momenta Pharmaceuticals Provides Update on US Regulatory Strategy for M923, Proposed Biosimilar to HUMIRA |
Momenta |
|
Fri, 11/30/2018 - 10:42 |
Vietnam launches national program for pre-exposure prophylaxis for HIV |
PATH |
|
Tue, 11/27/2018 - 12:13 |
Tevas Generic Version of EpiPen (Epinephrine Injection, USP) Auto-Injector 0.3 mg Now Available in Limited Quantity in the United States |
Teva Pharmaceutical |
|
Wed, 11/07/2018 - 05:36 |
Momenta Pharmaceuticals Announces Publication of Phase 1 Study Data for Anti-FcRn Antibody, M281 |
Momenta |
|
Tue, 11/06/2018 - 05:53 |
Momenta Pharmaceuticals Announces Global Settlement with AbbVie to Enable Commercialization of M923, a Proposed Biosimilar to HUMIRA (adalimumab) |
Momenta |
|
Tue, 11/06/2018 - 05:18 |
Momenta Pharmaceuticals to Webcast Presentation at the Stifel 2018 Healthcare Conference |
Momenta |
|
Thu, 10/25/2018 - 06:01 |
Updated EpiPen 0.3mg and 0.15mg Adrenaline Auto- Injectors Update From Mylan |
Allergy UK |
|
Tue, 10/16/2018 - 07:43 |
Humiras Big Day It's EU Patent Expires Today |
American Counci... |
|
Thu, 10/11/2018 - 07:33 |
Momenta Pharmaceuticals to Host R&D Day on October 11, 2018 |
Momenta |
|
Thu, 09/27/2018 - 13:19 |
Extended use of EpiPen 0.3mg adrenaline autoinjector |
Allergy UK |
|
Tue, 09/18/2018 - 10:46 |
EpiPen Update from Mylan - Availability of EpiPen 0.3mg and EpiPen Jr 0.15mg Adrenaline Auto-Injectors |
Allergy UK |
|
Mon, 09/03/2018 - 04:02 |
Fujifilm 3D image analysis system SYNAPSE VINCENT wins Red Dot Award: Communication Design 2018 |
Fujifilm |
|
Mon, 08/27/2018 - 20:23 |
Fujifilm enters joint research agreement with Indiana University School of Medicine. |
Fujifilm |
|
Fri, 07/27/2018 - 19:59 |
Ben Coghlan wins 2018 Pharmacy Student of the Year Award |
PSA |
|
Mon, 07/23/2018 - 11:08 |
Pharmaceutical corporations are failing children with HIV |
MSF |
|
Mon, 06/11/2018 - 17:20 |
Americares Honors Mylan with Power of Partnership Award |
Viatris |
|
Mon, 06/11/2018 - 16:56 |
Americares President and CEO Michael J. Nyenhuis (middle) presents the Power of Partnership Award to Mylan at the HDA Business and Leadership |
Americares |
|
Thu, 05/31/2018 - 10:25 |
Rising prescription drug prices in focus at Rices Baker Institute |
RiceUniv |
|
Wed, 05/09/2018 - 07:08 |
Mylan Statement on Supply of EpiPen (epinephrine injection, USP) Auto-Injectors from Meridian Medical Technologies, a Pfizer company |
Viatris |
